These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 30632843)

  • 41. Patients' and hematologists' concerns regarding tyrosine kinase-inhibitor therapy in chronic myeloid leukemia.
    Jiang Q; Yu L; Gale RP
    J Cancer Res Clin Oncol; 2018 Apr; 144(4):735-741. PubMed ID: 29380058
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gab2 signaling in chronic myeloid leukemia cells confers resistance to multiple Bcr-Abl inhibitors.
    Wöhrle FU; Halbach S; Aumann K; Schwemmers S; Braun S; Auberger P; Schramek D; Penninger JM; Laßmann S; Werner M; Waller CF; Pahl HL; Zeiser R; Daly RJ; Brummer T
    Leukemia; 2013 Jan; 27(1):118-29. PubMed ID: 22858987
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sustained molecular remissions are achievable with tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia and additional cytogenetic clonal evolution.
    Falchi L; Rege-Cambrin G; Fava C; Donti E; Luzi D; Giugliano E; Gubbiotti M; Schippa M; Liberati AM
    Cancer Genet Cytogenet; 2010 Jun; 199(2):139-42. PubMed ID: 20471518
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Response to Therapy, Treatment Intolerance and Tyrosine Kinase Inhibitor Cessation Eligibility in a Real-World Cohort of Chronic Myeloid Leukaemia Patients.
    McMullan RR; McConville C; McMullin MF
    Ulster Med J; 2019 May; 88(2):105-110. PubMed ID: 31061559
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pregnancy and long-term outcomes of female patients with chronic myeloid leukemia on tyrosine kinase inhibitors who experienced unplanned pregnancies.
    Bhattacharjee U; Jandial A; Singh C; Lekshmon KS; Mishra K; Sandal R; Nampoothiri R; Naseem S; Suri V; Jain A; Lad DP; Prakash G; Khadwal A; Malhotra P
    Leuk Res; 2023 Oct; 133():107367. PubMed ID: 37566974
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Planned pregnancy in a chronic myeloid leukemia patient in molecular remission.
    Pavlovsky C; Giere I; Van Thillo G
    Case Rep Hematol; 2012; 2012():624590. PubMed ID: 22928126
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chronic Myeloid Leukemia and Pregnancy: When Dreams Meet Reality. State of the Art, Management and Outcome of 41 Cases, Nilotinib Placental Transfer.
    Abruzzese E; Aureli S; Bondanini F; Ciccarone M; Cortis E; Di Paolo A; Fabiani C; Galimberti S; Malagola M; Malato A; Martino B; Trawinska MM; Russo D; de Fabritiis P
    J Clin Med; 2022 Mar; 11(7):. PubMed ID: 35407407
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nilotinib induced avascular necrosis of femoral head in an adult chronic myeloid leukemia patient.
    Thekkudan SF; Nityanand S
    J Clin Orthop Trauma; 2018 Jun; 9(Suppl 2):S26-S28. PubMed ID: 29928099
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Successful pregnancy and delivery in a patient with chronic myeloid leukemia: a case report and review of the literature.
    Sheng W; Sun N
    Springerplus; 2016; 5(1):2055. PubMed ID: 27995032
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Management of chronic myeloid leukemia during pregnancy: a retrospective analysis at a single center.
    Moura AC; Delamain MT; Duarte GBO; Lorand-Metze I; Souza CA; Pagnano KBB
    Hematol Transfus Cell Ther; 2019; 41(2):125-128. PubMed ID: 31079659
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.
    Abou Dalle I; Jabbour E; Short NJ; Ravandi F
    Curr Treat Options Oncol; 2019 Jan; 20(1):4. PubMed ID: 30675645
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Risks and challenges of CML management during pregnancy: Looking for a balanced decision.
    Chelysheva E; Turkina A
    Eur J Haematol; 2019 Apr; 102(4):378-379. PubMed ID: 30672625
    [No Abstract]   [Full Text] [Related]  

  • 53. Cardiovascular Risk and Cardiovascular Events in Patients With Chronic Myeloid Leukemia Treated With Tyrosine Kinase Inhibitors.
    Assunção PM; Lana TP; Delamain MT; Duarte GO; Zulli R; Lorand-Metze I; de Souza CA; de Paula EV; Barbosa Pagnano KB
    Clin Lymphoma Myeloma Leuk; 2019 Mar; 19(3):162-166. PubMed ID: 30660512
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Delayed methotrexate clearance in patients with acute lymphoblastic leukemia concurrently receiving dasatinib.
    Ramsey LB; Mizuno T; Vinks AA; O'Brien MM
    Pediatr Blood Cancer; 2019 May; 66(5):e27618. PubMed ID: 30677213
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dasatinib and low-intensity chemotherapy for Philadelphia chromosome-positive acute lymphoblastic leukemia in a child with Down syndrome.
    Hirabayashi S; Hasegawa D; Yamamoto K; Nishimura A; Hosoya Y; Shuo T; Kiyokawa N; Miura M; Takahashi N; Manabe A
    Pediatr Blood Cancer; 2019 May; 66(5):e27612. PubMed ID: 30663211
    [No Abstract]   [Full Text] [Related]  

  • 56. Renal dysfunction and anemia associated with long-term imatinib treatment in patients with chronic myelogenous leukemia.
    Sakurai M; Kikuchi T; Karigane D; Kasahara H; Matsuki E; Hashida R; Yamane Y; Abe R; Koda Y; Toyama T; Kato J; Shimizu T; Yokoyama Y; Suzuki S; Nakamura T; Okamoto S; Mori T
    Int J Hematol; 2019 Mar; 109(3):292-298. PubMed ID: 30680668
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Planned Pregnancy in Female Patients with Chronic Myeloid Leukemia Receiving Tyrosine Kinase Inhibitor Therapy.
    Dou X; Qin Y; Huang X; Jiang Q
    Oncologist; 2019 Nov; 24(11):e1141-e1147. PubMed ID: 31186377
    [TBL] [Abstract][Full Text] [Related]  

  • 58. European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia.
    Hochhaus A; Baccarani M; Silver RT; Schiffer C; Apperley JF; Cervantes F; Clark RE; Cortes JE; Deininger MW; Guilhot F; Hjorth-Hansen H; Hughes TP; Janssen JJWM; Kantarjian HM; Kim DW; Larson RA; Lipton JH; Mahon FX; Mayer J; Nicolini F; Niederwieser D; Pane F; Radich JP; Rea D; Richter J; Rosti G; Rousselot P; Saglio G; Saußele S; Soverini S; Steegmann JL; Turkina A; Zaritskey A; Hehlmann R
    Leukemia; 2020 Apr; 34(4):966-984. PubMed ID: 32127639
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pregnancy Outcomes in Chronic Myeloid Leukemia: A Single Center Experience.
    Madabhavi I; Sarkar M; Modi M; Kadakol N
    J Glob Oncol; 2019 Sep; 5():1-11. PubMed ID: 31584851
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Management of chronic myeloid leukemia during pregnancy among patients treated with a tyrosine kinase inhibitor: a single-Center experience.
    Assi R; Kantarjian H; Keating M; Pemmaraju N; Verstovsek S; Garcia-Manero G; Ravandi F; Borthakur G; Dahl J; Jabbour E; Cortes JE
    Leuk Lymphoma; 2021 Apr; 62(4):909-917. PubMed ID: 33283580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.